Serum amyloid A (SAA): Biochemistry, genetics and the pathogenesis of AA amyloidosis

References

• Cohen A S. Amyloidosis. N Engl Med 1967; 277: 522–530; 574–583; 628–638
   PubMed Web of Science ®Google Scholar
• Glenner G G. Amyloid deposits and amyloidosis. N Engl Med 1980; 302: 1283–1292
   PubMed Web of Science ®Google Scholar
• Husby G. Amyloidosis. Semin Arthritis Rheum 1992; 22: 67–82
   PubMedGoogle Scholar
• Cooper J H. Selective amyloid staining as a function of amyloid composition an structure. Histochemical analysis of the alkaline Congo red, standardized tolui-dine blue, and iodine methods. Lab Invest 1974; 31: 232–238
   PubMed Web of Science ®Google Scholar
• Husby G. Amyloidosis and rheumatoid arthritis. Clin Exp Rheumatol 1985; 3: 173–180
   PubMed Web of Science ®Google Scholar
• Cohen A S, Calkins E. Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature 1959; 183: 1202–1203
   PubMed Web of Science ®Google Scholar
• Benditt E P, Eriksen N. Starch gel electrophoretic analysis of some proteins extracted from amyloid. Arch Pathol 1964; 78: 325–330
   PubMedGoogle Scholar
• Pras M, Schubert M, Zucker-Franklin D, Rimon A, Franklin E. The characterization of soluble amyloid prepared in water. J Clin Invest 1968; 47: 924–933
   PubMed Web of Science ®Google Scholar
• Husby G. A chemical classification of amyloidosis - Correlation with different clinical types of amyloidosis. Scand J Rheumatol 1980; 9: 60–54
   PubMedGoogle Scholar
• Scott D L, Marhaug G, Husby G. Comparative studies of the high molecular weight amyloid fibril proteins and similar components from normal tissues. Clin Exp Immunol 1983; 52: 693–701
   Google Scholar
• van Andel A CJ, Niewold T A, Lutz B TG, Messing M WJ, Gruys E. The significance of non-protein AA material in water-soluble bovine AA-amyloid fibrils. Amyloidosis, J Marrink, M H van Rijswijk. Martinus Nijhoff, DordrechtThe Netherlands 1986; 169–175
   Google Scholar
• Husby G, Shukuro A, Benditt E P, Benson M D, Cohen A S, Frangione B, Glenner G G, Natvig J B, Westermark P. The 1990 guidelines for nomenclature and classification of amyloid and amyloidosis. Amyloid and Amyloidosis 1990, J B Natvig, Ø Forre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer Academic Publishers, DordrechtThe Netherlands 1991; 7–11
   Google Scholar
• Benditt E P, Araki S. Chemical clases of amyloid substance. Am J Pathol 1971; 65: 231–252
   PubMed Web of Science ®Google Scholar
• Muckle T J. The “Muckle-Wells” syndrome. Br J Dermatol 1979; 100: 87–92
   PubMedGoogle Scholar
• Linke R P, Heilmann K L, Nathrath W BJ, Eulitz M. Identification of amyloid A protein in a sporadic Muckle-Wells syndrome. N-terminal amino acid sequence after isolation from formalin-fixed tissue. Lab Invest 1983; 48: 698–704
   PubMed Web of Science ®Google Scholar
• Benditt E P, Eriksen M, Hermodsen M A, Ericsson L H. The major proteins of human and monkey amyloid substance: common properties including unusual N-terminal amino acid sequences. FEBS Lett 1971; 19: 169–173
   PubMed Web of Science ®Google Scholar
• Husebekk A, Skogen B, Husby G, Marhaug G. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol 1985; 21: 283–287
   PubMed Web of Science ®Google Scholar
• Tape C, Tan R, Nesheim M, Kisilevsky R. Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits. Scand J Immunol 1988; 28: 317–324
   PubMed Web of Science ®Google Scholar
• Levin M, Pras M, Franklin E C. Immunologic studies of the major nonimmunoglobulin protein of the amyloid.I. Identification and partial characterization of a related serum component. J Exp Med 1973; 138: 373–380
   PubMed Web of Science ®Google Scholar
• Husby G, Natvig J B, Michaelsen T E, Sletten K, Hest H. Unique amyloid protein subunit common to different types of amyloid fibrils. Nature 1973; 244: 362–364
   PubMedGoogle Scholar
• Husby G, Natvig J B. A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. J Clin Invest 1974; 53: 1054–1061
   PubMed Web of Science ®Google Scholar
• Betts J C, Edbrooke M R, Thakker R V, Woo P. The human acute-phase serum amyloid A gene family: structure, evolution and expression in hepatoma cells. Scand J Immunol 1991; 34: 471–482
   PubMed Web of Science ®Google Scholar
• Lowell C A, Stearman R S, Morrow J F. Transcriptional regulation of serum amyloid A gene expression. J Biol Chem 1986; 261: 8453–8461
   PubMed Web of Science ®Google Scholar
• Whitehead A S, de Beer M C, Steel D M, Rits M, Lelias J M, Lane W S, de Beer F C. Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem 1992; 267: 3862–3867
   PubMed Web of Science ®Google Scholar
• Steel D M, Sellar G C, Uhlar C M, Simon S, de Beer F C, Whitehead A S. A constitutively expressed serum amyloid A protein gene (SAA4) is closely linked to, and shares structural similarities with, an acute-phase serum amyloid A protein gene (SAA2). Genomics 1993; 16: 447–454
   PubMed Web of Science ®Google Scholar
• Benditt E P, Eriksen N. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci USA 1977; 74: 4025–4028
   PubMed Web of Science ®Google Scholar
• Benditt E P, Eriksen N, Hanson R H. Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein. Proc Natl Acad Sci USA 1979; 76: 4092–4096
   PubMed Web of Science ®Google Scholar
• Parmelee D C, Titani K, Ericsson L H, Eriksen N, Benditt E P, Walsh K A. Amino acid sequence of amyloid-related apoprotein (apoSAA) from human high-density lipoprotein. Biochemistry 1983; 21: 3298–3303
   Google Scholar
• Sletten K, Marhaug G, Husby G. The covalent structure of amyloid-related serum protein SAA from two patients with inflammatory disease. Hoppe-Seylers Zeitschrift fur Physiologische Chemie 1983; 364: 1039–1046
   Google Scholar
• Sletten K, Husby G. The complete amino-acid sequence of non-immunoglobulin amyloid fibril protein AS in rheumatoid arthritis. Eur J Biochem 1974; 41: 117–125
   PubMedGoogle Scholar
• Dwulet F E, Wallace D K, Benson M D. Amino acid structures of multiple forms of amyloid-related serum protein SAA from a single individual. Biochemistry 1988; 27: 1677–1682
   PubMed Web of Science ®Google Scholar
• Raynes J G, McAdam K PWJ. Serum amyloid A isoforms in inflammation. Scand JImmunol 1991; 33: 657–666
   Google Scholar
• Strachan A F, De Beer F C, van der Westhuyzen D R, Coetzee G A. Identification of three isoform patterns of human serum amyloid A protein. Biochem J 1988; 250: 203–207
   PubMedGoogle Scholar
• Beach C M, de Beer M C, Sipe J D, Loose L D, de Beer F C. Human serum amyloid A protein. Complete amino acid sequence of a new variant. Biochem J 1992; 282: 615–620
   PubMed Web of Science ®Google Scholar
• Steinkasserer A, Weiss E H, Schwaelbe W, Linke R P. Heterogeneity of human serum amyloid A protein. Five different variants from one individual demonstrated by cDNA sequence analysis. (1990). Biochem J 1990; 268: 187–193
   Google Scholar
• Sletten K, Husebekk A, Husby G. The primary structure of equine serum amyloidA (SAA) protein. Scand J Immunol 1989; 30: 117–122
   PubMed Web of Science ®Google Scholar
• Marhaug G, Husby G, Dowton S B. Mink serum amyloid A protein. Expression and primary structure based on cDNA sequences. J Biol Chem 1990; 265: 10049–10050
   Google Scholar
• Syversen P V, Juul J, Marhaug G, Husby G, Sletten K. The primary structure of serum amyloid A protein in the sheep; Comparison with serum amyloid A in other species. Scand J Immunol 1994; 39: 88–94
   PubMed Web of Science ®Google Scholar
• Syversen P V, Sletten K, Marhaug G, Husby G, Lium B. The revised amino acid sequence of serum amyloid A (SAA) protein in mink. Scand J Immunol 1993; 37: 696–697
   PubMedGoogle Scholar
• Syversen P V, Sletten K, Husby G. Evolutionary aspects of protein SAA. Amyloid and Amyloidosis, J B Natvig, Ø Forre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark, 1990; 111–114
   Google Scholar
• Yamamoto K-I, Migita S. Complete primary structures of two major murine serum amyloid A proteins deduced from cDNA sequences. Proc Natl Acad Sci USA 1985; 82: 2915–2919
   PubMed Web of Science ®Google Scholar
• Lowell C A, Potter D A, Stearman R S, Morrow J F. Structure of the murine serum amyloid A gene family. J Biol Chem 1986; 261: 8442–8452
   PubMed Web of Science ®Google Scholar
• de Beer M C, Beach C M, Shedlofsky S I, De Beer F C. Identification of a novel serum amyloid A protein in BALB/c mice. Biochem J 1991; 280: 45–49
   PubMed Web of Science ®Google Scholar
• de Beer M C, de Beer F C, Beach C M, Carreras I, Sipe J D. Mouse serum amyloidA protein. Complete amino acid sequence and mRNA analysis of a new isoform. Biochem J 1992; 283: 673–678
   PubMed Web of Science ®Google Scholar
• de Beer M C, de Beer F C, McCubbin W D, Kay C M, Kindy M S. Structural prerequisites for serum amyloid A fibril formation. J Biol Chem 1993; 268: 20606–20612
   PubMed Web of Science ®Google Scholar
• Sipe J D, Carreras I, Gonnerman W A, Cathcart E S, de Beer M C, de Beer F C. Characterization of the inbred CE/J mouse strain as amyloid resistant. Am J Pathol 1993; 143: 1480–1485
   PubMed Web of Science ®Google Scholar
• Brisette L, Young I, Narindrasorasak S, Kisilevsky R, Deely R. Differential induction of the serum amyloid A gene family in response to an inflammatory agent and to amyloid-enhancing factor. J Biol Chem 1989; 264: 19327–19332
   PubMed Web of Science ®Google Scholar
• Meek R L, Benditt E P. Amyloid A gene family expression in different mouse tissues. J Exp Med 1986; 164: 2006–2017
   PubMed Web of Science ®Google Scholar
• Meek R L, Eriksen N, Benditt E P. Serum amyloid A in the mouse. Sites of uptake and mRNA expression. Am J Pathol 1989; 135: 411–419
   Google Scholar
• Rokita H, Shirahama T, Cohen A S, Meek R L, Benditt E P, Sipe J D. Differential expression of the amyloid SAA 3 gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes. J Immunol 1987; 139: 3849–3853
   PubMed Web of Science ®Google Scholar
• Benditt E P, Meek R L. Expression of the third member of the serum amyloid A gene family in mouse adipocytes. J Exp Med 1989; 169: 1841–1846
   PubMed Web of Science ®Google Scholar
• Meek R, Eriksen N, Benditt E P. Mouse SAA3 detection in mouse tissues with specific antibody. Amyloid and Amyloidosis 1990, J B Natvig, Ø Ferre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer Academic Publishers, DordrechtThe Netherlands 1991; 75–78
   Google Scholar
• Meek R L, Eriksen N, Benditt E P. Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc Natl Acad Sci USA 1992; 89: 7949–7952
   PubMed Web of Science ®Google Scholar
• Rossevatn K, Andresen P K, Sletten K, Husby G, Nordstoga K, Johnson K H, Westermark P. The complete amino acid sequence of bovine serum amyloid protein A (SAA) and of subspecies of the tissue-deposited amyloid fibril protein A. Scand J Immunol 1992; 35: 217–224
   PubMed Web of Science ®Google Scholar
• Liepnieks J J, Dwulet F E, Benson M D, Kluve-Beckerman B, Kushner I. The primary structure of serum amyloid A protein in the rabbit: Comparison with serum amyloidA proteins in other species. J Lab Clin Med 1991; 118: 570–575
   PubMed Web of Science ®Google Scholar
• Syversen P V, Juul J, Rygg M, Sletten K, Husby G, Marhaug G. The primary structure of rabbit serum amyloid A protein isolated from acute phase serum. Scand J Immunol 1993; 37: 447–451
   PubMed Web of Science ®Google Scholar
• de Beer M C, de Beer F C, Beach C M, Gonnerman W A, Carreras I, Sipe J D. Syrian and Armenian hamsters differ in serum amyloid A gene expression. J Immunol 1993; 150(12)5361–5370
   Google Scholar
• Ericsson L H, Eriksen N, Walsh K A, Benditt E P. Primary structure of duck amyloid A proteins: The form deposited in tissues may be identical to its serum precursor. FEBS Lett 1987; 218: 11–16
   PubMed Web of Science ®Google Scholar
• Tatum F, Alam J, Smith A, Morgan W T. Molecular cloning, nucleotide sequence heterozygosity and regulation of rabbit serum amyloid A cDNA. Nucleic Acids Res 1990; 18: 7447
   Google Scholar
• Rygg M, Marhaug G, Husby G, Dowton S B. Rabbit serum amyloid A: Expression and primary structure deduced from cDNA sequences. Scand J Immunol 1991; 34: 727–734
   Google Scholar
• Ray B K, Ray A. Complementary DNA cloning and nucleotide sequence of rabbit serum amyloid A protein. Biochem Biophys Res Cotnm 1991; 178: 68–72
   Google Scholar
• Webb C F, Tucker P W, Dowton S B. Expression and sequence analyses of serum amyloid A in the Syrian hamster. Biochemistry 1989; 28: 4785–4790
   PubMedGoogle Scholar
• Mitchell T I, Coon C I, Brinckerhoff C E. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralized with specific antiserum. J Clin Invest 1991; 87: 1177–1185
   PubMed Web of Science ®Google Scholar
• Rygg M, Husby G, Marhaug G. Differential expression of rabbit serum amyloid A genes in response to various inflammatory agents. Scand J Immunol 1993; 38: 417–422
   Google Scholar
• Rygg M, Nordstoga K, Husby G, Marhaug G. Expression of serum amyloid A genes in mink during induction of inflammation and amyloidosis. Biochim Biophys Acta 1993; 1216: 402–408
   Google Scholar
• Kluve-Beckerman B, Drumm M L, Benson M. Nonexpression of the serum amyloid A three (SAA3) gene. DNA Cell Biol 1991; 10: 651–661
   Google Scholar
• Kisilevsky R. Serum amyloid A (SAA), a protein without a function: Some suggestions with reference to cholesterol metabolism. Med Hypotheses 1991; 35: 337–341
   PubMed Web of Science ®Google Scholar
• Ramadori G, Sipe J D, Dinarello C A, Mizel S B, Colten H R. Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J Exp Med 1985; 162: 930–942
   PubMed Web of Science ®Google Scholar
• Marinkovic S, Jahreis G P, Wong G G, Baumann H. IL-6 modulates the synthesis of a specific set of acute plasma proteins in vivo. J Immunol 1989; 142: 808–812
   PubMed Web of Science ®Google Scholar
• Woo P, Sipe J D, Dinarello C A, Colten H R. Structure of human serum amyloid A gene and modulation of its expression in transfected L cells. J Biol Chem 1987; 262: 15790–15795
   PubMed Web of Science ®Google Scholar
• Damtew B, Rzewnicki D, Lozanski G, Kushner I. IL-1 receptor antagonist affects the plasma protein response of Hep 3B cells to conditioned medium from li-popolysaccharide-stimulated monocytes. J Immunol 1993; 150: 4001–4007
   Web of Science ®Google Scholar
• Rokita H, Loose L D, Bartle L M, Sipe J D. Synergism of Interleukin 1 and Interleukin 6 induces serum amyloid A production while depressing fibrinogen: a quantitative analysis. J Rheumatol 1994; 21: 400–405
   PubMed Web of Science ®Google Scholar
• Raynes J G, Bevan S, Hosp M, McAdam K PWJ, Strain A J. Inhibition of SAA synthesis. Abstracted. Kisilevsky R, VII International Symposium on Amyloidosis, Kingston, OntarioCanada, 1993, 31
   Google Scholar
• Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 1990; 7: 147–152
   PubMedGoogle Scholar
• Dowton S B, Peters C N, Jestus J J. Regulation of serum amyloid A gene expression in Syrian hamsters by cytokines. Inflammation 1991; 15: 391–397
   Google Scholar
• Li X, Liao W SL. Cooperative effects of C/EBP-like and NFkB-like binding sites on rat serum amyloid Al gene expression in liver cells. NuclAcids Res 1992; 20: 4765–4772
   PubMedGoogle Scholar
• Huang J H, Rienhoff H Y, Jr, Liao W SL. Regulation of mouse serum amyloid A gene expression in transfected hepatoma cells. Mol Cell Biol 1990; 10: 3619–3625
   PubMedGoogle Scholar
• Li X, Huang J H, Rienhoff H Y, Jr, Liao W S. Two adjacent C/EBP-binding sequences that participate in the cell-specific expression of the mouse serum amyloid A3 gene. Mol Cell Biol 1990; 10: 6624–6631
   PubMedGoogle Scholar
• Edbrooke, Burt D W, Cheshire J K, Woo P. Identification of cis-acting sequences responsible for phorbol ester induction of human serum amyloid A gene expression via a nuclear factor B-like transcription factor. Mol Cell Biol 1989; 9: 1908–1916
   PubMed Web of Science ®Google Scholar
• Woo P, Edbrooke M R, Betts J, Watson G, Francis P. Serum amyloid A gene regulation. Acute Phase Proteins, Molecular Biology, Biochemistry and Clinical Applications, A Mackiewicz, I Kushner, H Baumann. CRC Press, Boca Raton 1993; 397–408
   Google Scholar
• Sipe J D. Amyloidosis. Ann Rev Biochem 1992; 61: 947–975
   PubMed Web of Science ®Google Scholar
• Gorevic P D, Levo Y, Frangione B, Franklin E C. Polymorphism of tissue and serum amyloid A (AA and SAA) proteins in the mouse. J Immunol 1978; 121: 138–140
   Google Scholar
• Bausserman L L, Herbert P N, McAdam K PWJ. Heterogeneity of human serum amyloid A proteins. J Exp Med 1980; 152: 641–656
   PubMed Web of Science ®Google Scholar
• Bausserman L L, Saritelli A L, Herbert P N, McAdam K PWJ, Shulman R S. NH2-terminal analysis of four of the polymorphic forms of human serum amyloid A proteins. Biochim Biophys Acta 1982; 704: 556–559
   PubMed Web of Science ®Google Scholar
• Sack G H, Jr. Molecular cloning of human genes for serum amyloid A. Gene 1983; 21: 19–24
   PubMed Web of Science ®Google Scholar
• Sack G H, Jr, Talbot C C, Jr. The human serum amyloid A locus SAA4 is a pseudogene. Biochem Biophys Res Commun 1992; 183: 362–366
   PubMed Web of Science ®Google Scholar
• Strachan A F, Brandt W F, Woo P, van der Westhuyzen D R, Coetzee G A, de Beer M C, Shepard E G, de Beer F C. Human serum amyloid A protein: The assignment of the six major isoforms to three published gene sequences and evidence for two genetic loci. J Biol Chem 1989; 264: 18368–18373
   PubMed Web of Science ®Google Scholar
• Kluve-Beckermann B, Long G L, Benson M D. DNA sequence evidence for polymorphic forms of human serum amyloid A (SAA). Biochem Genet 1986; 24: 795–803
   Google Scholar
• Kluve-Beckerman B, Brinckerhoff C, Benson M D. Sequence analysis of a third human SAA gene. Amyloid and Amyloidosis 1990, J B Natvig, Ø Force, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer Academic Publishers, DordrechtThe Netherlands 1991; 24–27
   Google Scholar
• Kluve-Beckerman B, Naylor S L, Marshall A, Gadner J C, Shows T B, Benson M D. Localization of human SAA gene(s) to chromosome 11 and detection of DNA polymorphisms. Biochem Biophys Res Commun 1986; 137: 1196–1204
   PubMed Web of Science ®Google Scholar
• Sack G H, Talbot C C. Highly polymorphic domains of the human serum amyloid A (SAA) gene GSAA1. Scand J Immunol. 1991; 33: 485–488
   Google Scholar
• Sipe J D, Colten H R, Goldberger G, Edge M D, Tack B F, Cohen A S, Whitehead A S. Human serum amyloid A (SAA): Biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry 1985; 24: 2931–2936
   PubMed Web of Science ®Google Scholar
• Woo P, Betts J, Edbrooke M. The human serum amyloid A genes and their regulation by inflammatory cytokines. Amyloid and Amyloidosis 1990, J B Natvig, Ø Farre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer Academic Publishers, DordrechtThe Netherlands 1990; 13–19
   Google Scholar
• Taylor B A, Rowe L. Genes for serum amyloid A proteins map to chromosome 7 in the mouse. Mol Gen Genet 1984; 195: 491–499
   PubMedGoogle Scholar
• Yamamato K-I, Goto N, Kosaka J, Shiroo M, Yeul Y D, Migata S. Structural diversity of murine serum amyloid A genes: Evolutionary implications. J Immunol 1987; 139: 1683–1688
   Google Scholar
• Hoffman J S, Ericsson L H, Eriksen E, Walsh K A, Benditt E P. Murine tissue amyloid protein AA, NH2-terminal sequence identity with only one of two serum amyloid proteins (apoSAA) gene products. J Exp Med 1984; 159: 641–646
   PubMed Web of Science ®Google Scholar
• Goldberger G, Bing D H, Sipe J D, Rits M, Colten H R. Transcriptional regulation of genes encoding the acute-phase proteins CRP, SAA and C3. J Immunol 1987; 138: 396–3971
   Google Scholar
• Paek I, Axel R. Glucocorticoids enhance stability of human growth hormone mRNA. Mol Cell Biol 1987; 1: 1496–1507
   Google Scholar
• Shiels B R, Northemann W, Gehring M R, Fey G H. Modified nuclear processing of a 1-acid glycoprotein RNA during inflammation. J Biol Chem 1987; 262: 12826–12831
   PubMedGoogle Scholar
• Cochrane A W, Deeley R G. Estrogen-dependent activation of the avian very low density apolipoprotein II and vitellogenin genes. J Mol Biol 1988; 203: 555–567
   Google Scholar
• Baltz M L, Rowe I F, Caspi D, Turnell W G, Pepys M B. Acute- phase high density lipoprotein in the rat does not contain serum amyloid A protein. Biochem J 1987; 242: 301–303
   PubMed Web of Science ®Google Scholar
• Hoffman J S, Benditt E P. Secretion of serum amyloid protein-rich high density lipoprotein in primary mouse hepatocyte culture. J Biol Chem 1982; 257: 10518–10522
   PubMed Web of Science ®Google Scholar
• Hoffman J S, Benditt E P. Changes in high-density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subtractions. J Biol Chem 1982; 257: 10510–10517
   PubMed Web of Science ®Google Scholar
• Marhaug G, Sletten K, Husby G. Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA). Clin Exp Immunol 1982; 50: 382–389
   PubMed Web of Science ®Google Scholar
• Feussner G, Ziegler R. Detection of human serum amyloid A protein in very low density - and high density lipoproteins of patients after acute myocardial infarction. Electrophoresis 1989; 10: 776–780
   Google Scholar
• Turnell W G, Sarra R, Glover I D, Baum J O, Caspi D. Secondary structure prediction of human SAA1. Presumptive identification of calcium and lipid binding sites. Mol Biol Med 1986; 3: 387–407
   PubMedGoogle Scholar
• Husebekk A, Skogen B, Husby G. Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoprotein (HDL). Scand J Immunol 1987; 25: 375–381
   PubMed Web of Science ®Google Scholar
• Marhaug G. Three assays for the characterization and quantitation of human serum amyloid A. Scand J Immunol 1983; 18: 329–338
   PubMedGoogle Scholar
• Parks J S, Rudel L L. Alteration of high density lipoprotein subtraction distribution with induction of serum amyloid A protein (SAA) in non-human primate. J Lipid Res 1985; 26: 82–91
   Google Scholar
• Saile R, Kabbaj O, Visvikis S, Steinmetz J, Steinmetz A, Ferard G, Fruchart J C, Metais P. Variation in apolipoproteins serum amyloid A, A-I, A-II, and C-III in severely head-injured patients. J Clin Chem Clin Biochem 1990; 28: 519–525
   Google Scholar
• Coetzee G A, Strachan A F, van der Westhuyzen D R, Hoppe H C, Jeenah M S, de Beer F C. Serum amyloid A-containing human high density lipoprotein 3. JBiol Chem 1986; 261: 9644–9651
   PubMed Web of Science ®Google Scholar
• van der Westhuyzen D R, Coetzee G A, de Beer F C. Serum amyloid A protein in plasma: characteristics of acute phase HDL. Amyloidosis, J Marrink, M H Van Rijswijk. Martinus Nijhoff Publishers, DordrechtThe Netherlands 1986; 115–125
   Google Scholar
• Aldo-Benson M A, Benson M D. SAA suppression of immune response in vitro: Evidence for an effect on T cell - macrophage interaction. J Immunol 1982; 126: 2390–2392
   Google Scholar
• Badalato R, Wang J M, Kelvin D, Oppenheim J J. Serum amyloid A is a potent chemotactic factor for monocytes. J Immunol 1993; 150: 217A
   Web of Science ®Google Scholar
• Steinmetz A, Hocke G, Sa'ile R, Puchois P, Fruchart J-C. Influence of serum amyloid A on cholesterol esterificatio in human plasma. Biochim Biophys Acta 1989; 1006: 173–178
   PubMed Web of Science ®Google Scholar
• Glomset J A. The plasma lecithinsxholesterol acyltransferase reaction. J Lip Res 1968; 9: 155–167
   PubMed Web of Science ®Google Scholar
• Liang J S, Sipe J D. The acute phase response protein serum amyloid A (apoSAA) alters cholesterol flux. J Cell Biochem 1994; 18B: 324, (Supplement)
   Google Scholar
• Meek R L, Urieli-Shoval S, Benditt E P. Expression of human apoSAA gene in cells of atherosclerotic lesions. Abstracts of VII International Symposium on Amyloidosis, Kingston, OntarioCanada, 1993, R Kisilevsky. 44
   Google Scholar
• de Beer F C, Navab M. High density lipoprotein function during active rheumatoid arthrits. Arthritis Rheum 1993; 36: SI29
   Google Scholar
• Shainkin-Kestenbaum R, Berlyne G, Zimlichman S, Sorin H R, Nyska M, Danon A. Acute phase protein, serum amyloid A, inhibits IL-1 - and TNF-induced fever and hypothalamic PGE2 in mice. Scand J Immunol 1991; 34: 179–183
   Web of Science ®Google Scholar
• Mitchell T I, Jeffrey J J, Palmiter R D, Brinckerhoff C E. The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin. Biochim Biophys Acta 1993; 1156: 245–254
   PubMedGoogle Scholar
• Linke R P, Bock V, Valet G, Rothe G. Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein. Biochem Biophys Res Commun. 1991; 176: 1100–1105
   PubMed Web of Science ®Google Scholar
• Zimlichman S, Danon A, Nathan I, Mozes G, Shaikin-Kestenbaum R. Serum amyloid A, an acute phase protein, inhibits platelet activation. J Lab Clin Invest 1990; 116: 180–186
   Google Scholar
• Levartowsky D, Pras M. The effect of SAA-de-rived fragment -SAA282 - on platelet aggregation. Amyloid and Amyloidosis 1990, J B Natvig, Ø Farre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer Academic Publishers, DordrechtThe Netherlands 1991; 129–132
   Google Scholar
• Kushner I. The phenomenon of the acute phase response. In: C-reactive protein and the plasma protein response to tissue injury. Ann N Y Acad Sci 1982; 389: 39–48
   PubMed Web of Science ®Google Scholar
• Casl M-T, Grubb A. A rapid enzyme-linked immunosorbent assay for serum amyloid A using sequence-specific antibodies. Ann Clin Biochem 1993; 30: 278–286
   Google Scholar
• Wilkins J, Gallimore J R, Moore E G, Pepys M B. Automated immunoassay for SAA. Abstract of VII International Symposium on Amyloidosis, Kingston, OntarioCanada, 1993, R Kisilevsky. 60
   Google Scholar
• de Oliveira R M, Sipe J D, de Beer F C, Loose L D, Bartle L M, Cecil D, Franzblau C. Rapid, sensitive enzyme-linked immunosorbent assays (ELISA) for serum amyloid A (apoSAA) in human plasma and tissue culture fluids. Amyloid Int J Exp Clin Invest 1994; 23–29
   Google Scholar
• Mozes M D, Friedman N, Shainkin-Kestenbaum R. Serum amyloid A: An extremely sensitive marker for intensity of tissue damage in trauma patients and indicator of acute phase response in various diseases. J Trauma 1989; 29: 71–74
   Google Scholar
• Marhaug G, Hårklau L, Olsen B, Husby G, Husebekk A, Wang H. Serum amyloid A protein in acute myocardial infarction. Acta Med Scand 1986; 220: 303–306
   PubMedGoogle Scholar
• Van Rijswijk M H. Amyloidosis. Thesis, University of Groningen, The Netherlands 1981
   Google Scholar
• Miwata H, Yamada T, Okada M, Kudo T, Kimura H, Morishima T. Serum amyloid A protein in acute viral infections. Arch Dis Child 1993; 68: 210–214
   PubMed Web of Science ®Google Scholar
• Marhaug G, Permin H, Husby G. Amyloid-related serum protein (SAA) as an indicator of lung infection in cystic fibrosis. Acta Pcediatr Scand 1983; 11: 861–866
   Google Scholar
• Chambers R E, Hutton C W, Dieppe P A, Whicher J T. Comparative study of C reactive protein and serum amyloid A protein in experimental inflammation. Ann Rheum Dis 1991; 50: 677–679
   Google Scholar
• Maury C PJ, Teppo A-M. Comparative study of serum amyloid-related protein and β-2-microglobulin as markers of renal allograft rejection. Clin Nephrol 1984; 11: 284–292
   Google Scholar
• Lalli E, Meliconi R, Conte R, Mancini A, Uguchioni M, Stefanini G F, Gasbarrini G. Serum markers of immune activation and liver allograft rejection. Dig Dis Sci 1992; 37: 1116–1120
   Google Scholar
• Maury C PJ, Tötterman K J, Gref C-G, Ehnholm C. Serum amyloid A protein, apolipoprotein A-1, and apolipoprotein B during the course of acute myocardial infarction. J Clin Pathol 1988; 41: 1263–1268
   Google Scholar
• Bausserman L L, Sadaniantz A, Saritelli A L, Martin V L, Nugent A M, Sady S P, Herbert P N. Time course of serum amyloid A response in myocardial infarction. Clin Chim Acta 1989; 184: 297–306
   PubMedGoogle Scholar
• Chambers R E, Stress P, Barry R E, Whicher J T. Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease. Eur J Clin Invest. 1987; 17: 460–467
   PubMed Web of Science ®Google Scholar
• Bausserman L L, Saritelli A L, Van Zuiden P, Gollaher C J, Herbert P N. Degradation of serum amyloid A by isolated perfused rat liver. J Biol Chem 1987; 262: 1583–1589
   PubMed Web of Science ®Google Scholar
• Gollaher C J, Bausserman L L. Hepatic catabolism of serum amyloid A during an acute phase response and chronic inflammation. Proc Soc Exp Biol Med 1990; 194: 245–250
   PubMed Web of Science ®Google Scholar
• Shirahama T, Cohen A S. Intralysosomal formation of amyloid fibrils. Am J Pathol 1975; 81: 101–116
   PubMed Web of Science ®Google Scholar
• Fuks A, Zucker-Franklin D. Impaired Kupffer cell function precedes development of secondary amyloidosis. J Exp Med 1985; 161: 1013–1028
   PubMed Web of Science ®Google Scholar
• Lavie G, Zucker-Franklin D, Franklin E C. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes. J Exp Med 1978; 148: 1020–1031
   PubMed Web of Science ®Google Scholar
• Skogen B, Thorsteinsson L, Natvig J B. Degradation of protein SAA to an AA-like fragment by enzymes of monocytic origin. Scand J Immunol 1980; 11: 533–540
   PubMed Web of Science ®Google Scholar
• Shirahama T, Miura K, Ju S T, Kisilevsky R, Gruys E, Cohen A S. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. Lab Invest 1990; 62: 61–68
   PubMed Web of Science ®Google Scholar
• Meek R L, Hoffman J S, Benditt E P. Amyloidogenesis. One serum amyloid A isotype is selectively removed from circulation. J Exp Med 1986; 163: 499–510
   PubMed Web of Science ®Google Scholar
• Shiroo M, Kawahara E, Nakanishi I, Migita S. Specific deposition of serum amyloid A protein 2 in the mouse. Scand J Immunol 1987; 26: 709–716
   PubMed Web of Science ®Google Scholar
• Gervais F, Hebert L. Apo-SAAl/apo-SAA2 isotype ratios during casein- and amyloid-enhancing-factor induced secondary amyloidosis in A/J and C57BL/6J mice. Scand J Immunol 1990; 31: 167–173
   Google Scholar
• Waalen K, Sletten K, Husby G, Nordstoga K. The primary structure of amyloid fibril protein AA in endotoxin-induced amyloidosis of the mink. Eur J Biochem 1980; 104: 407–417
   PubMedGoogle Scholar
• Niewold T A, Gruys E, Arakawa T, Shirahama T, Kisilevsky R. Recombinant human tumour necrosis factor-alpha (rhTNF-alpha) and rhTNF-alpha analogue enhance amyloid deposition in the Syrian hamster. Scand J Immunol 1993; 37: 29–32
   PubMed Web of Science ®Google Scholar
• Levin M, Franklin E C, Frangione B, Pras M. The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest 1972; 51: 2773–2776
   PubMed Web of Science ®Google Scholar
• Møyner K, Sletten K, Husby G, Natvig J B. An unusually large (83 amino acid residues) amyloid fibril protein AA from a patient with Waldenstrams macroglobulinaemia and amyloidosis. Scand J Immunol 1980; 11: 549–554
   PubMed Web of Science ®Google Scholar
• Baba S, Takahashi T, Kasama T, Shirasawa H. Identification of two novel amyloid A protein subsets coexisting in an individual patient of AA-amyloidosis. Biochim Biophys Acta 1992; 1180: 195–200
   PubMed Web of Science ®Google Scholar
• Baba S, Takahashi T, Kasama T, Fujie M, Shirasawa H. A novel polymorphism of human serum amyloid A protein, SAA1, is characterized by alanines at both residues 52 and 57. Biochim Biophys Acta 1992; 1180: 195–200
   PubMed Web of Science ®Google Scholar
• Hazenberg B PC, Limburg P C, Bijzet J, Van Rijswijk M H. SAA isoform patterns in patients with and without AA-amyloidosis. Abstract of VIIth International Symposium on Amyloidosis, Kingston, OntarioCanada, 1983, R Kisilevsky. 51
   Google Scholar
• Westermark G T, Engström U, Per Westermark. The N-terminal segment of protein AA determines its fibrillogenic property. Biochem Biophys Res Commun 1992; 182: 27–33
   PubMed Web of Science ®Google Scholar
• Anders R F, Natvig J B, Sletten K, Husby G, Nordstoga K. Amyloid-related serum protein SAA from three animal species: Comparison with human SAA. JImmunol 1977; 118: 229–234
   PubMed Web of Science ®Google Scholar
• Husby G, Magnus J H, Marhaug G, Nordvag B Y, Stenstad T, Sletten K (1993) Protein, polysaccharide and ionic interactions in amyloidosis. Proceedings of the VII International Symposium on Amyloidosis, KingstonCanada, July, 1993, R Kisilevsky, (in press)
   Google Scholar
• Hardy J A, Higgings G A. Alzheimer's Disease: The amyloid cascade hypothesis. Science 1992; 256: 184–185
   PubMed Web of Science ®Google Scholar
• Nel A E, De Beer M C, Shephard E G, Strachan A F, Vandenplas M L, De Beer F C. Phosphorylation of human serum amyloid A protein by protein kinase C. Biochem J 1988; 255: 29–34
   PubMed Web of Science ®Google Scholar
• Syversen V. Studies on serum amyloid protein A. Thesis, The University of Oslo, Norway 1993
   Google Scholar
• Suzuki T, Nairn A C, Candy S E, Greengard P. Phosphorylation of Alzheimer amyloid precursor protein by protein kinase C. Neuroscience 1992; 48: 755–761
   Google Scholar
• Lyon A W, Anastassiades T, Kisilevsky R. In vivo analysis of murine serum sulfate metabolism and splenic glycosaminoglycan biosynthesis during acute inflammation and amyloidosis. J Rheumatol 1993; 20: 1108–1113
   PubMed Web of Science ®Google Scholar
• Stenstad T, Magnus J H, Husby G. Characterization of glycosaminoglycans and proteolgycans in advanced murine AA amyloidosis. Proceedings of the VII International Symposium on Amyloidosis, KingstonCanada, July, 1993, R Kisilevsky, (in press)
   Google Scholar
• Westermark G T, Sletten K, Grubb A, Westermark P. AA-amyloidosis: Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAa gene product. Am J Pathol 1990; 137: 377–383
   PubMed Web of Science ®Google Scholar
• Eriksen N, Ericsson L H, Pearsall N, Lagunoff D, Benditt E P. Mouse amyloid protein AA: Homology with non-immunoglobulin protein of human and monkey amyloid substance. Proc Natl Acad Sci USA 1976; 73: 964–967
   PubMed Web of Science ®Google Scholar
• Sletten K, Husebekk A, Husby G. The amino acid sequence of an amyloid fibril protein AA isolated from the horse. Scand J Immunol 1987; 26: 79–84
   PubMed Web of Science ®Google Scholar
• Stearman R S, Lowell C A, Peltzman C G, Morrow J F. The sequence and structure of a new serum amyloid A gene. Nucleic Acids Res 1986; 14: 797–809
   PubMed Web of Science ®Google Scholar
• Rokita H, Shirahama T, Cohen A S, Sipe J D. Serum amyloid A gene expression and AA amyloid formation in A/J and SJL/J mice. Brit J Exp Path 1989; 70: 327–335
   PubMedGoogle Scholar
• de Beer M C, Kindy M S, Lane W S, de Beer F C. Mouse serum amyloid A protein (SAA5) structure and expression. J Biol Chem 1994; 269: 4661–4667
   PubMed Web of Science ®Google Scholar
• Gervais F, Suh M. Serum amyloid A protein-related mRNA expression in Herpes simple virus type 2-transformed hamster cells. Mol Cell Biol 1990; 10: 4412–4414
   PubMedGoogle Scholar